Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

dc.contributor.authorTewari, D.en_US
dc.contributor.authorJava, J. J.en_US
dc.contributor.authorSalani, R.en_US
dc.contributor.authorArmstrong, D. K.en_US
dc.contributor.authorMarkman, M.en_US
dc.contributor.authorHerzog, T.en_US
dc.contributor.authorMonk, B. J.en_US
dc.contributor.authorChan, J. K.en_US
dc.contributor.cuauthorMonk, Bradley J.en_US
dc.date.accessioned2015-06-23T20:15:55Z
dc.date.available2015-06-23T20:15:55Z
dc.date.issued2015en_US
dc.date.monthMarch 23en_US
dc.date.year2015en_US
dc.identifier.citationTewari, D.; Java, J. J.; Salani, R.; Armstrong, D. K.; Markman, M.; Herzog, T.; Monk, B. J.; Chan, J. K. (2015). Long-Term Survival Advantage and Prognostic Factors Associated with Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015 March 23 doi: http://doi.org/10.1200/JCO.2014.55.9898en_US
dc.identifier.issn1527-7755en_US
dc.identifier.issn0732-183Xen_US
dc.identifier.pmid25800756en_US
dc.identifier.urihttp://hdl.handle.net/10504/69175
dc.language.isoeng_USen_US
dc.program.unitSchool of Medicineen_US
dc.program.unitPhoenix Campus (Medicine)en_US
dc.program.unitObstetrics and Gynecologyen_US
dc.publisherby American Society of Clinical Oncologyen_US
dc.titleLong-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Studyen_US
dc.title.workJournal of Clinical Oncologyen_US
dc.typeJournal Articleen_US
dc.url.link1http://doi.org/10.1200/JCO.2014.55.9898en_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: